Safety study of enicepatide in healthy Chinese adults
This early-stage study tests how a new drug called enicepatide is tolerated and processed by the body in generally healthy adults. Researchers want to understand the drug's safety profile before it might be tested in people with specific health conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a generally healthy adult with no active or chronic diseases
- Your BMI (body mass index) must be 23 kg/m² or higher at screening
- You must have a normal heart rhythm on an ECG (heart electrical test)
- You must have normal results on blood and other lab tests
- You must be willing to use contraception during the study if applicable
- You cannot have a history of pancreas inflammation, gallbladder disease, serious depression, or significant heart, kidney, liver, or other major organ problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called ICP-538 in healthy people to see how safe it is and how the body processes it. It is an early-phase study that helps decide if the drug can move to testing in patients with a specific condition.
This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.
This trial tests if enicepatide can help people with obesity or overweight lose weight, including those with or without type 2 diabetes. It aims to see if the drug is safe and effective.
This study tests a new injectable medication called enicepatide for people with obesity or overweight who have not been able to lose weight through diet and exercise alone. It may help you lose weight and improve health conditions linked to excess weight.
This trial tests an investigational medication, Enicepatide, to see if it helps people with obesity or overweight and type 2 diabetes lose weight and improve blood sugar control. You will receive weekly injections and regular check-ups.
This trial tests a new medicine (CKD-339) in healthy people to see how the body processes it and if it is safe. It is an early-stage study that could help develop a treatment for conditions like high blood pressure or heart problems.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.